UBS AM’s 1Life Healthcare ONEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-165,237
| Closed | -$2.76M | – | 2748 |
|
|
2022
Q4 | $2.76M | Buy |
165,237
+4,532
| +3% | +$76.6K | ﹤0.01% | 1393 |
|
|
2022
Q3 | $2.76M | Sell |
160,705
-17,127
| -10% | -$269K | ﹤0.01% | 1435 |
|
|
2022
Q2 | $1.39M | Sell |
177,832
-38,156
| -18% | -$328K | ﹤0.01% | 1793 |
|
|
2022
Q1 | $2.39M | Buy |
215,988
+100,515
| +87% | +$1.13M | ﹤0.01% | 1709 |
|
|
2021
Q4 | $2.03M | Buy |
115,473
+14,057
| +14% | +$273K | ﹤0.01% | 1869 |
|
|
2021
Q3 | $2.05M | Buy |
101,416
+741
| +0.7% | +$19K | ﹤0.01% | 1822 |
|
|
2021
Q2 | $3.33M | Buy |
100,675
+19,968
| +25% | +$754K | ﹤0.01% | 1597 |
|
|
2021
Q1 | $3.15M | Buy |
80,707
+3,890
| +5% | +$183K | ﹤0.01% | 1557 |
|
|
2020
Q4 | $3.35M | Buy |
76,817
+35,972
| +88% | +$1.23M | ﹤0.01% | 1460 |
|
|
2020
Q3 | $1.16M | Buy |
40,845
+23,245
| +132% | +$734K | ﹤0.01% | 1780 |
|
|
2020
Q2 | $639K | Buy |
+17,600
| New | +$496K | ﹤0.01% | 2011 |
|
UBS AM's ONEM Position: Q1 2023 in Review
UBS AM sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 165,237 shares — an estimated $2.76M sold.
UBS AM first reported a position in ONEM in Q2 2020 and held it in 11 quarters. The position peaked at $3.35M in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.
- UBS AM reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
- UBS AM sold 165,237 1Life Healthcare shares in Q1 2023, an estimated $2.76M.
- UBS AM first reported a position in 1Life Healthcare in Q2 2020 and held it in 11 quarters.
- UBS AM's 1Life Healthcare position peaked at $3.35M in Q4 2020.
- 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.